|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 130.91 USD | -0.21% |
|
+4.20% | +94.52% |
| 10-15 | PPI data gives Wall Street another headache |  |
| 10-15 | Analyst recommendations: Crocs, IBM, Microsoft, Morgan Stanley, Rollins… | |
| Market Cap | 14.86B 13.31B 12.24B 11.09B 20.73B 1,411B 21.12B 146B 58.6B 742B 55.76B 54.58B 2,340B | P/E 2026 * |
17.9x | P/E 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 16.37B 14.66B 13.48B 12.22B 22.84B 1,554B 23.26B 161B 64.54B 817B 61.42B 60.11B 2,578B | EV / Sales 2026 * |
8.7x | EV / Sales 2027 * | 7.26x |
| Free-Float |
98.92% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| HALO | Delayed | |
CBOE
| HALO | Real-time | |
|
Tradegate
| RV7 | Real-time | |
|
Borsa Italiana
| 1HALO | End-of-day quote | |
|
Boerse Muenchen
| RV7 | Real-time | |
|
Deutsche Boerse AG
| RV7 | Delayed | |
|
Mexican S.E.
| HALO * | End-of-day quote | |
|
Xetra
| RV7 | Delayed | |
|
London S.E.
| 0J2O | Delayed | |
|
Berne S.E.
| RV7 | End-of-day quote | |
|
Börse Stuttgart
| RV7 | Delayed |
Last Transcript: Halozyme Therapeutics, Inc.
| 1 day | -0.21% | ||
| 1 week | +4.20% | ||
| 1 month | +18.58% | ||
| 3 months | +58.60% | ||
| 6 months | +105.64% | ||
| Current year | +94.52% |
| 1 week | 126.03 |  | 134 |
| 1 month | 106.65 | | 134 |
| Current year | 61.32 | | 134 |
| 1 year | 61.22 | | 134 |
| 3 years | 33.15 | | 134 |
| 5 years | 29.85 | | 134 |
| 10 years | 8.18 | | 134 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 05/01/2014 |
| Director of Finance/CFO | - | 07/06/2026 | |
David Ramsay
DFI | Director of Finance/CFO | 61 | 30/04/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 27/03/2013 |
Helen Torley
BRD | Director/Board Member | 63 | 05/01/2014 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/10/26 | Exercice | Chief Executive Officer | 60,000 | 0.0529% | ||
| 01/10/26 | Sell | Director | -5,230 | 0.0046% | ||
| 01/10/26 | Free | Director | 2,944 | 0.0026% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.21% | +4.20% | +100.81% | +286.51% | 14.86B | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.86% | +5.73% | +52.01% | +104.76% | 427.68B | |
| Weighted average by Cap. | +2.00% | +6.59% | +50.68% | +101.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.88B 1.68B 1.55B 1.4B 2.62B 179B 2.67B 18.48B 7.42B 93.95B 7.06B 6.91B 296B | 2.1B 1.88B 1.73B 1.57B 2.93B 199B 2.99B 20.63B 8.28B 105B 7.88B 7.71B 331B |
| Net income | 883M 791M 728M 659M 1.23B 83.88B 1.26B 8.68B 3.48B 44.12B 3.32B 3.24B 139B | 1.08B 968M 890M 807M 1.51B 103B 1.54B 10.62B 4.26B 53.99B 4.06B 3.97B 170B |
| Net Debt | 1.51B 1.35B 1.24B 1.13B 2.1B 143B 2.14B 14.82B 5.95B 75.33B 5.66B 5.54B 238B | 396M 355M 326M 296M 552M 37.6B 563M 3.89B 1.56B 19.78B 1.49B 1.45B 62.37B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | US$130.91 | -0.21% | 1,402,422 |
| 29/10/26 | US$131.18 | +0.88% | 1,875,467 |
| 28/10/26 | US$130.03 | +1.19% | 1,725,379 |
| 27/10/26 | US$128.50 | +0.38% | 1,699,538 |
| 26/10/26 | US$128.01 | +1.89% | 1,237,636 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
